Document is current
Any future updates will be listed below
-
Authors
Kwon, Yoonsung
Blazyte, Asta
Jeon, Yeonsu
Kim, Yeo Jin
An, Kyungwhan
Jeon, Sungwon
Ryu, Hyojung
Shin, Dong-Hyun
Ahn, Jihye
Um, Hyojin
Kang, Younghui
Bak, Hyebin
Kim, Byoung-Chul
Lee, Semin
Jung, Hyung-Tae
Shin, Eun-Seok
Bhak, Jong
-
Funding
Funding for this research was provided by:
Ministry of SMEs and Startups (1425157253, 1425157253, 1425157253, 1425157253, 1425157253, 1425157253, 1425157253, 1425157253, 1425157253, 1425157253, 1425157253, 1425157253, 1425156792, 1425156792, 1425157253)
Ministry of Trade, Industry and Energy (1415170577, 1415170577, 1415170577, 1415170577, 1415170577, 1415170577, 1415170577, 1415187694, 1415187694, 1415187694, 1415187694, 1415187694, 1415170577)
Ulsan National Institute of Science and Technology (1.200108.01, 1.200108.01, 1.200108.01, 1.200108.01, 1.200108.01, 1.200108.01, 1.200108.01)
- License Information
-
More Information
Article History
Received: 23 January 2024
Accepted: 13 January 2025
First Online: 17 February 2025
Declarations
:
: Written informed consent was obtained from all participants in this study. Sample collection and sequencing were approved by the Institutional Review Board (IRB) of the Ulsan Medical Center (USH.20.013) and Ulsan National Institute of Science and Technology (UNISTIRB-15–19-A).
: Y.J., Yeo Jin K., S.J., H.R., J.A., H.U., Younghui K., H.B., and B.K. are employees, and J.B. is the CEO of Clinomics Inc. S.J. is the CEO of both AgingLab and Geromics. The authors declare no other competing interests.
